- Home
- DOYU vs JSPR Comparison
DOYU vs JSPR Comparison
Compare DOYU & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOYU
- JSPR
- Stock Information
- Founded
- DOYU 2014
- JSPR 2018
- Country
- DOYU China
- JSPR United States
- Employees
- DOYU 1336
- JSPR N/A
- Industry
- DOYU Computer Software: Programming Data Processing
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DOYU Technology
- JSPR Health Care
- Exchange
- DOYU Nasdaq
- JSPR Nasdaq
- Market Cap
- DOYU 352.1M
- JSPR 302.0M
- IPO Year
- DOYU 2019
- JSPR N/A
- Fundamental
- Price
- DOYU $10.88
- JSPR $22.54
- Analyst Decision
- DOYU Sell
- JSPR Strong Buy
- Analyst Count
- DOYU 4
- JSPR 10
- Target Price
- DOYU $7.03
- JSPR $74.86
- AVG Volume (30 Days)
- DOYU 136.9K
- JSPR 402.8K
- Earning Date
- DOYU 12-05-2024
- JSPR 11-07-2024
- Dividend Yield
- DOYU N/A
- JSPR N/A
- EPS Growth
- DOYU N/A
- JSPR N/A
- EPS
- DOYU N/A
- JSPR N/A
- Revenue
- DOYU $650,466,712.00
- JSPR N/A
- Revenue This Year
- DOYU N/A
- JSPR N/A
- Revenue Next Year
- DOYU N/A
- JSPR N/A
- P/E Ratio
- DOYU N/A
- JSPR N/A
- Revenue Growth
- DOYU N/A
- JSPR N/A
- 52 Week Low
- DOYU $6.29
- JSPR $4.00
- 52 Week High
- DOYU $20.17
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- DOYU 58.62
- JSPR 62.47
- Support Level
- DOYU $10.53
- JSPR $21.75
- Resistance Level
- DOYU $11.13
- JSPR $24.61
- Average True Range (ATR)
- DOYU 0.52
- JSPR 1.35
- MACD
- DOYU 0.21
- JSPR 0.27
- Stochastic Oscillator
- DOYU 91.14
- JSPR 67.06
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.